CRBSI Article Collection
- Victor Lange, BS, BA, MS, CRC, Director, Infection Control, Southwest Healthcare System, Mission Viejo, CA
- Sophie Harnage, B.S.N, R.N, Clinical Manger, Infusion Services, Sutter Roseville Medical Center, Roseville, CA.
- BACKGROUND/OBJECTIVES: Catheter Related Bloodstream Infections (CRBSIs) have been targeted for reduction at our 500-bed university-affiliated hospital since 2001. Prospective, house-wide surveillance for CRBSI revealed a cluster of CRBSIs with onset shortly after insertion (≤14 days) among patients with central catheters inserted in Interventional Radiology (IR) during the months of June through August 2002. METHODS: The use of Chloroprep®, a 2% CHG/70% alcohol skin prep (ALC/CHG) was introduced in June 2003.
- ISSUE: Catheter-related bloodstream infections (CRBSIs) affect over 200,000 patients per year in the United States, increasing mortality risk 4%–35% and costing an estimated $6,000–$40,000 per infection. Strict adherence to evidence-based practices has been shown to reduce nosocomial CRBSI. PROJECT: We studied the reduction of CRBSI using a modified Institute for Healthcare Improvement framework and attention to campaign strategies (military, political, and marketing) at intensive care units (ICUs) from four healthcare systems representing tertiary referral, moderate-sized community, and small rural facilities.
- ISSUE: Inconsistent use of the Center for Disease Control and Prevention (CDC) guidelines for prevention of CR-BSIs as well as lack of clear, concise communication between members of the healthcare team can result in CR-BSIs. Due to fluctuating CRBSI rates, a multiphased “safe passage” campaign was launched in our 50-bed NICU to address both issues. PROJECT: A teamwork and safety culture survey was conducted to provide a baseline measure. This was followed by a central line education and competency program.